Drug intelligence / Profile preview

Fiprocat

Development stage
Unknown
Lead developer
DÔMES PHARMA
Modality
Small Molecules
Administration
Topical
01

Overview

Fiprocat is a veterinary topical spot-on solution developed and marketed by Pure Med Farma (Pure Med Biotech) for the treatment and prevention of flea, tick, and biting lice infestations in cats. The active ingredient is fipronil, a broad-spectrum insecticide and acaricide belonging to the phenylpyrazole chemical family. Fipronil acts by disrupting the central nervous system of parasites through the potent inhibition of the gamma-aminobutyric acid (GABA)-gated chloride channel and the glutamate-gated chloride channel (GluCl). This interference leads to the hyperexcitation of the parasite's nerves and muscles, resulting in death. The spot-on formulation is designed for topical application, where it distributes across the animal's body surface and accumulates in the sebaceous glands, providing prolonged residual activity against ectoparasites.

Brand names
Fiprocat
Other names
Fiprocat Spot On Solution
02

Targets

GluCl (Glutamate-gated chloride channel)RDL (Insect GABA-gated chloride channel)

Beyond the preview

Go deeper on Fiprocat.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fiprocat.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call